Issue 4/2010

Transcription factor IIH – the protein complex with multiple functions (287 — 290)

Z. MYDLIKOVA, J. GURSKY, M. PIRSEL

DOI: 10.4149/neo_2010_04_287

Nestin expression in human tumors and tumor cell lines. (291 — 298)

O. KRUPKOVA_JR, T. LOJA, I. ZAMBO, R. VESELSKA

DOI: 10.4149/neo_2010_04_291

Identification of differential proteins in colon cancer SW480 cells with HIF1-α silence by proteome analysis (299 — 305)

X. Y. WU, Z. X. FU, X. H. WANG, W. SHEN

DOI: 10.4149/neo_2010_04_299

Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer (306 — 315)

A. ANGHEL, M. RAICA, D. NARITA, E. SECLAMAN, T. NICOLA, S. URSONIU, M. ANGHEL, E. POPOVICI

DOI: 10.4149/neo_2010_04_306

Dual inhibition of topoisomerases enhances apoptosis in melanoma cells (316 — 324)

K. RUDOLF, M. CERVINKA, E. RUDOLF

DOI: 10.4149/neo_2010_04_316

CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer (325 — 332)

P. PLEVOVA, D. CERNA, A. BALCAR, L. FORETOVA, J. ZAPLETALOVA, E. SILHANOVA, R. CURIK, J. DVORACKOVA

DOI: 10.4149/neo_2010_04_325

Excretion of estrogens, catecholestrogens and phytoestrogens in carriers of BRCA1 gene mutations: effects of metformin (333 — 338)

L. M. BERSTEIN, A. KOSKELA, M. P. BOYARKINA, H. ADLERCREUTZ

DOI: 10.4149/neo_2010_04_333

Antitumor activity of apoptotic nuclease TBN1 from L. esculentum. (339 — 348)

J. MATOUSEK, T. PODZIMEK, P. POUCKOVA, J. STEHLIK, J. ŠKVOR, P. LIPOVOVA, J. MATOUSEK

DOI: 10.4149/neo_2010_04_339

Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results. (349 — 354)

Z. MOLNAR, Z. SIMON, Z. BORBENYI, B. DEAK, L. GALUSKA, K. KERESZTES, Z. MILTENYI, I. MARTON, A. ROSTA, T. SCHNEIDER, L. TRON, E. VARADY, A. ILLES

DOI: 10.4149/neo_2010_04_349

Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic (355 — 359)

H. KLAMOVA, E. FABER, D. ZACKOVA, M. MARKOVA, J. VOGLOVA, E. CMUNT, L. NOVAKOVA, K. MACHOVA-POLAKOVA, J. MORAVCOVA, D. DVORAKOVA, K. MICHALOVA, J. BREZINOVA, A. OLTOVA, M. JAROSOVA, P. CETKOVSKY, K. INDRAK, J. MAYER

DOI: 10.4149/neo_2010_04_355

Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma (360 — 364)

J. QIU, Y. ZHANG, X. GUO, F. ZENG, C. ZHAO, X. QIU, X. WU

DOI: 10.4149/neo_2010_04_360

Deleted in Breast Cancer 1 (DBC1) is a dynamically regulated protein (365 — 368)

J. E. KIM, S. SUNG

DOI: 10.4149/neo_2010_04_365

Optimization and it’s influence on value of doses in HDR and PDR brachytherapy (369 — 376)

J. SKOWRONEK, G. ZWIERZCHOWSKI, T. PIOTROWSKI, P. MILECKI

DOI: 10.4149/neo_2010_04_369

No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma (377 — 381)

A. FURDOVA, P. SLEZAK, M. CHORVATH, I. WACZULIKOVA, M. SRAMKA, G. KRALIK

DOI: 10.4149/neo_2010_04_377